-
Single-Cell Transcriptomic Analysis of Kaposi Sarcoma
Study
phs003800
-
Discovery and Characterization of Genetic Risk Loci in Sjogren's Syndrome
Study
phs002723
-
Gabriella Miller Kids First (GMKF) Pediatric Research Program in Susceptibility to Ewing Sarcoma Based on Germline Risk and Familial History of Cancer
Study
phs001228
-
Cellular and Molecular Characterization of Renal Cell Carcinoma
Study
phs002252
-
Integration of Clinical and Molecular Biomarkers for Melanoma Survival (Berwick)
Study
phs003099
-
Genomic Sequencing of Pediatric Rhabdomyosarcoma
Study
phs000720
-
Integrated Somatic and Germline Molecular Properties Dictating Biological and Clinical Phenotypes in Cancer
Study
phs003438
-
A Personalized Neoantigen Vaccine Generates Anti-Tumor Immunity in High-Risk Renal Cell Carcinoma
Study
phs003710
-
Natural Killer Cell and Lymphocyte-Targeted Immunotherapies in Cancer
Study
phs002681
-
Genetic analysis of paired diagnosis and relapse neuroblastomas
Study
EGAS50000002000
-
Whole Genome Sequencing of cell-free-DNA in High-Risk Smoldering Multiple Myeloma
Study
EGAS50000001657
-
Multi-omics datasets (WES, RNA-seq) of mesothelioma MIST3 study, a phase IIA AXL/PD1 inhibition clinical trial
Study
EGAS50000001704
-
IMMUcan CRC1 cohort
Study
EGAS50000002159
-
IMMUcan CRCKUL CRC1 cohort
Study
EGAS50000002164
-
IMMUcan CRCCLB CRC1 cohort
Study
EGAS50000002170
-
IMMUcan CRCStLuc CRC1 cohort
Study
EGAS50000002185
-
Raw sequencing data from a phase 2 trial of dasatinib in patients with relapsed/refractory nodal T-follicular helper cell lymphoma
Study
EGAS50000002081
-
GOSH_Paediatric_Tumour_23P108_WSSS_WGS_Managed_Access
Study
EGAS00001007536
-
scRNA-seq Glioblastoma–PBMC Co-culture Dataset
Dataset
EGAD50000001617
-
Single cell atlas of follicular lymphoma
Study
EGAS50000002080
-
Potency-Guided Tumor-Infiltrating Lymphocyte Therapy in Metastatic Uveal Melanoma: A Phase 2 Trial
Study
phs004955
-
Intron Retention Regulates STAT2 Function and Predicts Response to Immunotherapy in Lung Adenocarcinoma
Study
phs004211
-
A Phase III Randomized Double-Blinded Study Comparing the Combination of the BRAF Inhibitor Dabrafenib and the MEK Inhibitor Trametinib to Dabrafenib and Placebo as First-Line Therapy in Subjects with Unresectable (Stage IIIC) or Metastatic (Stage IV) Melanoma
Study
phs004958
-
NCTN_NCORP: A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children (ACCL0431)
Study
phs004156
-
Multi-Platform Analysis of Matched Well- and Dedifferentiated Tumors Identify Novel Drivers of Liposarcomagenesis
Study
phs004774
-
Study the differences at the trascriptome level between iNKT and T cells
Study
EGAS00001003176
-
The molecular landscape of glioma in patients with Neurofibromatosis 1.
Study
EGAS00001003186
-
Alternative splicing in Shh-MB
Study
EGAS00001003220
-
Whole exome sequencing (bam files) of 55 samples of myxofibrosarcoma and 44 matched pairs
Study
EGAS00001005442
-
Summary statistics from genome-wide association study in glioma of 12,488 cases and 18,169 controls.
Study
EGAS00001003372
-
Pharmacogenomic landscape of patient-derived cells informs precision oncology therapy
Study
EGAS00001002515
-
Hypermutation of the inactive X chromosome is a frequent event in cancer
Study
EGAS00001000565
-
POT1_splice_site_mutant_analysis
Study
EGAS00001000571
-
46 patients primary malignant glioma cohort in Chinese population
Study
EGAS00001005583
-
Copy-number signatures and mutational processes in ovarian carcinoma
Study
EGAS00001002557
-
Single cell RNA-sequencing of GSCs and GBM tumours
Study
EGAS00001004656
-
Molecular Attributes Underlying Central Nervous System and Systemic Relapse in Diffuse Large B-cell Lymphoma
Study
EGAS00001004057
-
Whole genome sequencing with linked reads of pediatric glioblastoma samples
Study
EGAS00001003432
-
glioblastoma and glioblastoma stem cells (GSCs), RNA-seq and WGS
Study
EGAS00001004395
-
Molecular profiling of EBV associated diffuse large B-cell lymphoma
Study
EGAS00001006400
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Colorectal_LCM
Study
EGAS00001003455
-
NIBIT-M4 Clinical Trial samples
Study
EGAS00001006736
-
A Phase II Trial of High Dose Interleukin-2 and Multi-site Stereotactic Ablative Radiotherapy for Patients with Metastatic Renal Cell Carcinoma
Study
EGAS00001003605
-
Alveolar Rhabdomyosarcoma sequencing data
Study
EGAS00001005387
-
Microenvironment subtypes and association with tumor cell mutations and antigen expression in follicular lymphoma
Study
EGAS00001006052
-
Evolutionary dynamics of neuroblastoma
Study
EGAS00001004990
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Oesophageal_adenocarcinoma
Study
EGAS00001003702
-
The 3D evolution of glioma cell populations
Study
EGAS00001003710
-
Characterization of patient-derived xenograft models of myxoid liposarcoma either sentitive or resistant to trabectedin
Study
EGAS00001003715
-
Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif
Study
EGAS00001003719